Association between obesity and the brain-derived neurotrophic factor gene polymorphism Val66Met in individuals with bipolar disorder in Mexican population
- PMID: 27524902
- PMCID: PMC4966648
- DOI: 10.2147/NDT.S104654
Association between obesity and the brain-derived neurotrophic factor gene polymorphism Val66Met in individuals with bipolar disorder in Mexican population
Abstract
Background: The brain-derived neurotrophic factor (BDNF) has been considered as an important candidate gene in bipolar disorder (BD); this association has been derived from several genetic and genome-wide studies. A polymorphic variant of the BDNF (Val66Met) confers some differences in the clinical presentation of affective disorders. In this study, we evaluated a sample population from Mexico City to determine whether the BDNF (rs6265) Val66Met polymorphism is associated with the body mass index (BMI) of patients with BD.
Methods: This association study included a sample population of 357 individuals recruited in Mexico City. A total of 139 participants were diagnosed with BD and 137 were classified as psychiatrically healthy controls (all individuals were interviewed and evaluated by the Diagnostic Interview for Genetic Studies). Genomic DNA was extracted from peripheral blood leukocytes. The quantitative polymerase chain reaction (qPCR) assay was performed in 96-well plates using the TaqMan Universal Thermal Cycling Protocol. After the PCR end point was reached, fluorescence intensity was measured in a 7,500 real-time PCR system and evaluated using the SDS v2.1 software, results were analyzed with Finetti and SPSS software. Concerning BMI stratification, random groups were defined as follows: normal <25 kg/m(2), overweight (Ow) =25.1-29.9 kg/m(2), and obesity (Ob) >30 kg/m(2).
Results: In the present work, we report the association of a particular BMI phenotype with the presence of the Val66Met allele in patients with BD (P=0.0033 and odds ratio [95% confidence interval] =0.332 [157-0.703]), and correlated the risk for valine allele carriers with Ow and Ob in patients with BD.
Conclusion: We found that the methionine allele confers a lower risk of developing Ow and Ob in patients with BD. We also confirmed that the G polymorphism represents a risk of developing Ow and Ob in patients with BD. In future studies, the haplotype analysis should provide additional evidence that BDNF may be associated with BD and BMI within the Mexican population.
Keywords: bipolar disorder; body mass index; brain-derived neurotrophic factor; single nucleotide polymorphism.
Figures
Similar articles
-
Association Between the Brain-derived Neurotrophic Factor Val66Met Polymorphism and Overweight/Obesity in Pediatric Population.Arch Med Res. 2017 Oct;48(7):599-608. doi: 10.1016/j.arcmed.2018.02.005. Epub 2018 Mar 3. Arch Med Res. 2017. PMID: 29506764
-
The role of brain-derived neurotrophic factor (BDNF) Val66Met genetic polymorphism in bipolar disorder: a case-control study, comorbidities, and meta-analysis of 16,786 subjects.Bipolar Disord. 2015 Feb;17(1):27-38. doi: 10.1111/bdi.12227. Epub 2014 Jul 8. Bipolar Disord. 2015. PMID: 25041243
-
The impact of BDNF Val66Met polymorphism on cognition in Bipolar Disorder: A review: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.J Affect Disord. 2019 Jan 15;243:552-558. doi: 10.1016/j.jad.2018.07.054. Epub 2018 Jul 24. J Affect Disord. 2019. PMID: 30078664 Review.
-
Association study of BDNF Val66Met gene polymorphism with bipolar disorder and lithium treatment response in Indian population.J Psychopharmacol. 2021 Dec;35(12):1510-1516. doi: 10.1177/02698811211032609. Epub 2021 Jul 27. J Psychopharmacol. 2021. PMID: 34311608
-
Genetics of bipolar disorder: focus on BDNF Val66Met polymorphism.Novartis Found Symp. 2008;289:60-72; discussion 72-3, 87-93. doi: 10.1002/9780470751251.ch5. Novartis Found Symp. 2008. PMID: 18497095 Review.
Cited by
-
Associations of BDNF/BDNF-AS SNPs with Depression, Schizophrenia, and Bipolar Disorder.J Pers Med. 2023 Sep 18;13(9):1395. doi: 10.3390/jpm13091395. J Pers Med. 2023. PMID: 37763162 Free PMC article. Review.
-
From Metabolic Syndrome to Neurological Diseases: Role of Autophagy.Front Cell Dev Biol. 2021 Mar 19;9:651021. doi: 10.3389/fcell.2021.651021. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33816502 Free PMC article. Review.
-
Catechol-O-Methyltransferase Val158Met and brain-derived neurotrophic factor Val66Met gene polymorphisms in paraphilic sexual offenders.Indian J Psychiatry. 2019 May-Jun;61(3):253-257. doi: 10.4103/psychiatry.IndianJPsychiatry_194_18. Indian J Psychiatry. 2019. PMID: 31142902 Free PMC article.
-
Brain-Derived Neurotrophic Factor and Its Associations with Metabolism and Physical Activity in a Latino Sample.Metab Syndr Relat Disord. 2019 Mar;17(2):75-80. doi: 10.1089/met.2018.0028. Epub 2018 Nov 10. Metab Syndr Relat Disord. 2019. PMID: 30418087 Free PMC article.
-
Evidence that genes involved in hedgehog signaling are associated with both bipolar disorder and high BMI.Transl Psychiatry. 2019 Nov 21;9(1):315. doi: 10.1038/s41398-019-0652-x. Transl Psychiatry. 2019. PMID: 31754094 Free PMC article.
References
-
- Latalova K, Kamaradova D, Prasko J. Suicide in bipolar disorder: a review. Psychiatr Danub. 2014;26:108–114. - PubMed
-
- Smoller JW, Finn CT. Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet. 2003;123C:48–58. - PubMed
-
- Wu R, Fan J, Zhao J, Calabrese JR, Gao K. The relationship between neurotrophins and bipolar disorder. Expert Rev Neurother. 2014;14:51–65. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous